Multimodal treatment of hyperactive child includes psychostimulant medication, methylphenidate (MPH) marketed in France in its short-acting form since about ten years. We report our clinical experience about the first fifty methylphenidate responders who received one of the two sustained-release forms available since summer 2004, tablets of oros-methyphenidate (Concerta LP) or microgranule-filled capsules (Ritaline LP).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.arcped.2005.09.007 | DOI Listing |
Publication Analysis
Top Keywords
hyperactive child
8
[medical treatments
4
treatments hyperactive
4
child pharmaceutical
4
pharmaceutical forms
4
forms methylphenidate
4
methylphenidate marketed
4
marketed france]
4
france] multimodal
4
multimodal treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!